According to filings with the U.S. Securities and Exchange Commission, Otolith Labs is raising $24,799,853.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Samuel Owen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Otolith Labs
Otolith is the world-leader in vestibular masking technology. We build hardware products powered by science, data and clinical research for the treatment of vertigo. Otolith Labs is pioneering the first medical wearable for the treatment of chronic vertigo, a symptom experienced by 4-5 million Americans. Otolith’s patented non-invasive head-worn technology uses precisely tuned vibrations to interact with the motion sensors in the inner ear, mitigating the symptoms of vertigo. This novel technology has been validated by several clinical studies, including multiple independent studies at universities and with leading automotive manufacturers. 

To learn more about Otolith Labs, visit http://otolithlabs.com/

Contact:
Samuel Owen, Chief Executive Officer
571-263-3498
https://www.linkedin.com/in/samuel-owen-1aa20049/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.